Acta Pharmacologica Sinica, Published online: 17 August 2026; doi:10.1038/s41401-026-01896-5 Oxyberberine-nanoparticle attenuates the cognitive deficits in a transgenic mouse model of Alzheimer’s disease via modulating gut microbiota through suppressing CXCL10/CXCR3 pathway